PMC:7212965 / 66821-67235 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T156","span":{"begin":237,"end":242},"obj":"Body_part"}],"attributes":[{"id":"A156","pred":"fma_id","subj":"T156","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T124","span":{"begin":237,"end":242},"obj":"Body_part"}],"attributes":[{"id":"A124","pred":"uberon_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T334","span":{"begin":160,"end":168},"obj":"Disease"},{"id":"T335","span":{"begin":322,"end":330},"obj":"Disease"}],"attributes":[{"id":"A334","pred":"mondo_id","subj":"T334","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A335","pred":"mondo_id","subj":"T335","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T482","span":{"begin":237,"end":242},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T483","span":{"begin":237,"end":242},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T32283","span":{"begin":86,"end":88},"obj":"Chemical"},{"id":"T80568","span":{"begin":387,"end":390},"obj":"Chemical"},{"id":"T17066","span":{"begin":401,"end":410},"obj":"Chemical"},{"id":"T24559","span":{"begin":412,"end":414},"obj":"Chemical"}],"attributes":[{"id":"A83533","pred":"chebi_id","subj":"T32283","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A66468","pred":"chebi_id","subj":"T80568","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"},{"id":"A83564","pred":"chebi_id","subj":"T17066","obj":"http://purl.obolibrary.org/obo/CHEBI_16990"},{"id":"A69037","pred":"chebi_id","subj":"T24559","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T301","span":{"begin":322,"end":330},"obj":"Phenotype"},{"id":"T302","span":{"begin":341,"end":356},"obj":"Phenotype"},{"id":"T303","span":{"begin":364,"end":378},"obj":"Phenotype"}],"attributes":[{"id":"A301","pred":"hp_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A302","pred":"hp_id","subj":"T302","obj":"http://purl.obolibrary.org/obo/HP_0002017"},{"id":"A303","pred":"hp_id","subj":"T303","obj":"http://purl.obolibrary.org/obo/HP_0002027"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T545","span":{"begin":0,"end":117},"obj":"Sentence"},{"id":"T546","span":{"begin":118,"end":143},"obj":"Sentence"},{"id":"T547","span":{"begin":144,"end":220},"obj":"Sentence"},{"id":"T548","span":{"begin":221,"end":277},"obj":"Sentence"},{"id":"T549","span":{"begin":278,"end":331},"obj":"Sentence"},{"id":"T550","span":{"begin":332,"end":357},"obj":"Sentence"},{"id":"T551","span":{"begin":358,"end":379},"obj":"Sentence"},{"id":"T552","span":{"begin":380,"end":414},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2401","span":{"begin":160,"end":168},"obj":"Disease"},{"id":"2402","span":{"begin":318,"end":330},"obj":"Disease"},{"id":"2403","span":{"begin":341,"end":347},"obj":"Disease"},{"id":"2404","span":{"begin":348,"end":356},"obj":"Disease"},{"id":"2405","span":{"begin":364,"end":378},"obj":"Disease"}],"attributes":[{"id":"A2401","pred":"tao:has_database_id","subj":"2401","obj":"MESH:C000657245"},{"id":"A2402","pred":"tao:has_database_id","subj":"2402","obj":"MESH:D003967"},{"id":"A2403","pred":"tao:has_database_id","subj":"2403","obj":"MESH:D009325"},{"id":"A2404","pred":"tao:has_database_id","subj":"2404","obj":"MESH:D014839"},{"id":"A2405","pred":"tao:has_database_id","subj":"2405","obj":"MESH:D015746"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Chen, 202073The First Affiliated Hospital of Wanan Medical College (Wuhu)AnhuiDates: NA (Case series) n = 9Survival: 100% dischargedInclusion: Inpatients with COVID-19 confirmed on RT-PCR via swabAge: range, 25–56 ySex: 44.4% femalesGI/liver comorbidities: NRDisease severity: 55.6% moderately ill and 44.4% severely ill Diarrhea: 22.2% (2)Nausea/vomiting: 0% (0)Abdominal pain: 0% (0) AST, ALT, and bilirubin: NR"}